News

Researchers at Huntsman Cancer Institute are developing breast cancer models using tumors donated by patients to narrow the number of drugs that might be effective in each tumor based on the unique characteristics and behavior in these models of cancer.

Detection of skin cancer relies on visual examination, making it hard to reliably determine the skin cancer subtype and its extent of invasion into the skin. Researchers at Huntsman Cancer Institute have developed a potential new device to diagnose skin cancer using an electrical current.

Melanoma researchers at Huntsman Cancer Institute published a study that gives a new explanation of what causes moles to change into melanoma. These findings pave the way for more research into how to reduce the risk of melanoma, delay development, and detect melanoma early.

New research done by the Ullman and Sundquist Labs examines the important role of a quality control process—called an abscission checkpoint— in allowing cells to divide and replicate. Their findings may lead to better understanding of how cancers begin and become more aggressive.

Huntsman Cancer Institute melanoma researchers have generated the first “atlas” of where human melanocytes are located in the body. In analyzing the atlas data, the team discovered different types of melanocytes, including what looks to be the cell of origin for an understudied subtype called acral melanoma, which mostly affects people of color.

Liver cancer often doesn’t show symptoms until it has progressed to a late stage, which means it’s harder to treat successfully. Huntsman Cancer Institute researcher and pathologist Kimberley Evason, MD, PhD, wants to find better treatments for advanced liver cancer.

Mary Beckerle, PhD, describes how the clinical landscape has changed during her career, as well as discussing the future at Huntsman Cancer Institute and the unique relationship between its caregivers and patients.

Six new cancer researchers will receive funding through the 5 For The Fight Cancer Research Fellowship, which aims to bring innovative ideas and new ways of thinking to eradicate cancer.